Cite
HARVARD Citation
Flanagan, E. et al. (2022). Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero. Alimentary pharmacology & therapeutics. 55 (6), pp. 700-704. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Flanagan, E. et al. (2022). Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero. Alimentary pharmacology & therapeutics. 55 (6), pp. 700-704. [Online].